MedPath
NMPA Approval

Rifampin Isoniazid and Pyrazinamide Tablets

国药准字H20020188

July 24, 2020

Drug Information

异福酰胺片

维葆

片剂

0.45g(C43H58N4O12 0.12g,C6H7N3O 0.08g 与 C5H5N3O 0.25g)

化学药品

July 24, 2020

Company Information

Applicant Company

Manufacturing Company

苏州工业园区群星一路58号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

异福酰胺片 - NMPA 批准文号 | MedPath